Anthem , the second - biggest health insurer in the world , is partnering with healthcare and Harvard Medical School researchers on a 12-month innovative study which aims to determine the impact of AI on disease treatment and alternative healthcare . In a study , Anthem and colleagues acknowledged " data trials that rely on the confluence of blockchain , alternative medicine , and artificial intelligence are a fairly new concept " . A report by Accenture estimates healthcare 's AI costs will be worth more than $ 6bn by 2021 .
Anthem, the second-biggest health insurer in the US, is partnering with doc.ai and Harvard Medical School researchers on a 12-month innovative study which aims to determine the impact of AI on disease treatment and personalised healthcare. In a statement, Anthem and doc.ai acknowledged "data trials that rely on the confluence of blockchain, precision medicine, and artificial intelligence are a fairly new concept". A report by Accenture estimates healthcare's AI market will be worth more than $6bn by 2021.